Chronic kidney disease Clinical Trials Database - Free Access to 283 Studies
Access comprehensive clinical trial information for Chronic kidney disease through Pure Global AI's free database. This collection includes 283 clinical trials across multiple phases including N/A, Not Applicable, Early Phase 1. Currently, 53 trials are actively recruiting participants.
Research for Chronic kidney disease is being conducted in Japan, China, Iran and 7+ other countries. Leading sponsors include Hyogo College of Medicine and Guangdong Provincial Hospital of Chinese Medicine. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Impact of online medical assistance using a smartphone for primary physicians and patients with chronic kidney disease on clinical practice and patients' outcome.
A Phase 1b open label study of the pharmacokinetics and safety of oral OCX063 in adults with chronic kidney disease
Prospective observational study of the effects of D-alanine intake on amino acid metabolism
Untitled Trial
Effects of intake of 11/19-B1 Yogurt on dialysis patients.
Effects of nutrition education using behavioral science theory in junior high school students ~Raising awareness of chronic kidney disease and fostering health literacy~
A multicentre prospective cohort study on the effect of exercise and physical activity on functional decline, cardiovascular disease and mortality in patients undergoing hemodialysis
Untitled Trial
Outcome Measure of Pharmacist-led Intervention for Chronic Kidney Disease Patients
Untitled Trial
The Clinical Effects of Exercise in Non-obese Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis
Empagliflozin in stage 4 non-diabetic kidney disease
Investigation of the effect of hospitalization for kidney disease diet tasting on the progression of chronic kidney disease.
Untitled Trial
The effects of low protein Genmai in CKD patients
Untitled Trial
EFFECTS OF PHARMACEUTICAL CARE USING PROMPT QUESTIONNAIRE IN CHRONIC KIDNEY DISEASE PATIENTS
Safety and efficacy of a new solution, XyloCore, for peritoneal dialysis
Renal Outcome with Empagliflozin in non-diabetic Chronic Kidney Disease Patients: A Randomized Control Trial
A 6-month multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and PK/PD of an age-and body weight-adjusted oral finerenone regimen, in addition to an ACEI or ARB, for the treatment of children, 6 months to <18 years of age, with chronic kidney disease and proteinuria
Pure Global AI provides free access to 283 clinical trials studying Chronic kidney disease, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Hyogo College of Medicine, Guangdong Provincial Hospital of Chinese Medicine, University Hospitals of Leicester NHS Trust, among others.